Shom Goel

CDK4/6 inhibition triggers anti-tumour immunity

Shom Goel, Molly J. DeCristo, April C. Watt et al. · Nature · 2017 · 1.5K citations · Full text

Medicine, Cancer Biology, Oncology +12

TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma

Jieqiong Liu, Shan Liao, Benjamin Diop-Frimpong et al. · Proceedings of the National Academy of Sciences · 2012 · 325 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial

Sara M. Tolaney, Andrew Wardley, Stefania Zambelli et al. · The Lancet Oncology · 2020 · 261 citations

Medicine, Oncology, Pharmacology +16

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients

Sara M. Tolaney, Yves Boucher, Dan G. Duda et al. · Proceedings of the National Academy of Sciences · 2015 · 256 citations · Full text

Medicine, Oncology, Pharmacology +17

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim et al. · npj Breast Cancer · 2020 · 206 citations · Full text

Medicine, Oncology, Pathology +16